Clinical Trial Update: The PICM Risk Prediction Study - Application of AI to Pacing

View source ↗

Summary

This clinical trial update describes the PICM Risk Prediction Study, which applies artificial intelligence to pacing to predict pacemaker-induced cardiomyopathy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pacemaker-induced Cardiomyopathy
• Pacemaker-related Complications

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Heart Failure, Pacemaker-Induced Cardiomyopathy | Status: NOT_YET_RECRUITING